Article
Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence
2023-05-02
Abstract excerpt
<h4>STRUCTURED ABSTRACT</h4> <h4>Background</h4> Patients with localized prostate cancer have historically been assigned to clinical risk groups based on local disease extent, serum prostate specific antigen (PSA), and tumor grade. Clinical risk grouping is used to determine the intensity of treatment with external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT), yet a substantial proportion of pat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 84e2a153-7176-55c1-ace5-c3c8c9b20ea8
- DOI
- 10.1101/2023.05.01.23288883
